Regulatory Affairs

Canada-based legal and consulting practice advising regulated-industry clients on psychedelic access, controlled-substance pathways, constitutional/regulatory issues, and policy-facing market development.

Canadian business law firm with published advisory work on legal and regulatory frameworks for psychedelics companies, including public-market and disclosure implications under Canadian law.

Law firm providing psychedelic-sector legal counsel across DEA/FDA pathway navigation, transactional support, and healthcare-compliance risk management for clinics, facilitators, and research organizations.

Psychedelic and psilocybin-focused legal practice supporting operators and organizations with regulatory navigation, compliance strategy, and legal risk mitigation in emerging plant-medicine markets.

International regulatory affairs consultancy (UK/EU/US footprint) supporting life-science organizations across development to post-licensing, including dedicated analysis of psychedelic-drug regulatory pathways.

Brazil-based law firm with a leading IP and life-sciences practice, contributing legal and regulatory analysis on psychedelic medicines in Brazil and advising on IP-protection strategy in regulated sectors.

Toronto-based boutique law firm operating a dedicated psychedelic law practice, advising individuals and organizations on regulatory compliance, governance, contracts, and legal risk in Canada’s psychedelic sector.

National law firm with a dedicated psychedelics and emerging therapies legal practice supporting organizations operating in complex U.S. therapeutic, regulatory, and commercialization pathways.

Canadian law firm with a dedicated cannabis-and-psychedelics regulatory practice advising on Section 56 pathways, Special Access Program matters, licensing compliance, and controlled-substance legal strategy.

UK law firm with a dedicated psychoactive medicines practice providing regulatory, commercial, and IP counsel for psychedelic and cannabis organizations across research, clinic, and supply-chain contexts.

Toronto law firm focused on psychedelics and controlled-substance legal operations, supporting licensing strategy, Health Canada interactions, audit/inspection readiness, and compliance architecture across research-to-commercial pathways.

Psychedelic-focused law firm advising clinics, researchers, nonprofit organizations, and religious groups on controlled-substance licensing, compliance strategy, and policy-facing legal frameworks.

Law firm focused on cannabis and psychedelics law, with advisory work spanning FDA/DEA pathways, controlled-substance compliance, and policy implementation in emerging psychedelic regulatory programs.